Centene Corp. Given Neutral Rating at UBS AG (CNC)
Centene Corp. (NYSE:CNC)‘s stock had its “neutral” rating restated by analysts at UBS AG in a research report issued to clients and investors on Wednesday, American Banking News reports. They currently have a $62.00 price objective on the stock. UBS AG’s target price suggests a potential upside of 6.73% from the company’s current price.
In other Centene Corp. news, EVP Jason Harrold unloaded 5,000 shares of Centene Corp. stock on the open market in a transaction dated Wednesday, April 2nd. The stock was sold at an average price of $62.19, for a total transaction of $310,950.00. Following the transaction, the executive vice president now directly owns 48,382 shares in the company, valued at approximately $3,008,877. The transaction was disclosed in a filing with the SEC, which is available at this link.
Centene Corp. (NYSE:CNC) opened at 57.95 on Wednesday. Centene Corp. has a 52 week low of $43.49 and a 52 week high of $67.84. The stock’s 50-day moving average is $62.21 and its 200-day moving average is $60.74. The company has a market cap of $3.339 billion and a P/E ratio of 19.77.
Centene Corp. (NYSE:CNC) last released its earnings data on Tuesday, February 4th. The company reported $0.84 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.83 by $0.01. The company had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.93 billion. During the same quarter last year, the company posted $0.47 earnings per share. Centene Corp.’s revenue was up 29.0% compared to the same quarter last year. Analysts expect that Centene Corp. will post $3.59 EPS for the current fiscal year.
Several other analysts have also recently commented on the stock. Analysts at Susquehanna raised their price target on shares of Centene Corp. from $68.00 to $70.00 in a research note on Thursday, April 10th. They now have a “positive” rating on the stock. Separately, analysts at Leerink Swann raised their price target on shares of Centene Corp. from $68.00 to $71.00 in a research note on Wednesday, February 5th. Finally, analysts at Citigroup Inc. upgraded shares of Centene Corp. from a “sell” rating to a “neutral” rating in a research note on Wednesday, February 5th. They now have a $59.00 price target on the stock. Nine analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $68.61.
Centene Corporation is a multi-line healthcare enterprise, which provides programs and services to the number of under-insured and uninsured individuals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.